Reuters logo
BRIEF-Therapix signs exclusive license agreement with Yissum
April 5, 2017 / 1:13 PM / in 7 months

BRIEF-Therapix signs exclusive license agreement with Yissum

April 5 (Reuters) - Therapix Biosciences Ltd

* Therapix signs exclusive license agreement with Yissum for nasal drug delivery technology

* Therapix Biosciences - under terms of deal, Yissum to give co exclusive, sub-licensable, royalty-bearing license for nasal delivery of cannabinoids technology Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below